Peptide · Approved
Triptorelin
A GnRH agonist (Trelstar) for prostate cancer and central precocious puberty.
Key facts
- Also known as: Trelstar
- Status: Approved
- Used for: Cancer (GnRH agonist)
- Natural counterpart: An analog of natural GnRH.
- Target enzyme / receptor: GnRH receptor (GnRHR) — GPCR
- Signalling pathway: Gαq → down-regulation → ↓LH/FSH → ↓sex hormones
In plain terms: Overstimulates then switches off sex-hormone output. - Crystal / cryo-EM structure: Available PDB 7BR3 ↗
Status & safety
This is an approved medicine — prescription-only in most countries. Only use it under a licensed clinician, obtained through a pharmacy.
Research & clinical studies
Explore the biochemistry and clinical evidence for Triptorelin — these open live, date-sorted searches, so they always show the latest.
Read research papers on PubMed ↗
Clinical studies (ClinicalTrials.gov) ↗
Google Scholar ↗
Related guide →
All peptides & profiles →
Not medical advice. Chemdu is an educational resource and does not sell, prescribe or supply any peptide. Consult a licensed professional about any medicine or supplement.